US Food and Drug Administration staff want sponsors to better focus and prioritize issues for discussion at formal meetings under the Prescription Drug User Fee Act program.
Key Takeaways
-
The FDA wants sponsors to focus their questions for discussion at PDUFA meetings and recommends that patient advocate presentations be scheduled for the latter part of the meeting so pressing issues can be addressed first.